Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company's potential in a recent report.

Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company's potential in a recent report.

Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7% ...

Alibaba (NYSE:BABA) shares rose 3.5% in premarket trading on Wednesday as investment firm Citron Research continued to hype up the company's new Qwen AI models, launched earlier this week.

Teledoc (TDOC), which just acquired Catapult Health, is using technology the “right” way, by cutting costs, improving care, and expanding margins, all while making money, Citron Research says ...

This is why the shoutout from Citron Research was so surprising. The research firm has a large social media presence and called Teladoc "The Under-the-Radar AI Play," which is attention grabbing.

BOSTON, Jan. 27, 2025 /PRNewswire/ -- Dynamis LLP has filed a formal petition with the U.S. Securities and Exchange Commission (SEC) on behalf of prominent investor and Citron Research founder ...